RICHMOND, Va., Oct 24, 2005 (BUSINESS WIRE) -- Insmed Incorporated (NASDAQ: INSM) today announced that Philip J. Young, Chief Business Officer of Insmed, will present a corporate overview Tuesday, October 25 at 10:40am ET during the C.E. Unterberg, Towbin Emerging Growth Life Sciences Conference taking place in New York. Investors may access a live audio webcast of the presentation via Insmed's corporate website, www.insmed.com. A replay of the presentation will be available for one week.
About Insmed
Insmed is a biopharmaceutical company focused on the discovery and development of drug candidates for the treatment of metabolic diseases and endocrine disorders with unmet medical needs. For more information, please visit http://www.insmed.com.
Your Privacy Choices